Dayvigo vs. Halcion
See how Dayvigo and Halcion compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Dayvigo is a non-benzodiazepine orexin blocker approved for long-term nightly use, while Halcion is a benzodiazepine meant only for short courses of 7 to 10 days.
Both are Schedule IV controlled substances, but Halcion carries boxed warnings for abuse, dependence, and dangerous interactions with opioids.
Dayvigo has a flat two-dose system (5 mg or 10 mg), while Halcion offers three dose strengths (0.125 mg, 0.25 mg, 0.5 mg) adjusted to response.
Dayvigo vs. Halcion Drug Summary
Dayvigo
Dayvigo (lemborexant) is a dual orexin receptor antagonist prescribed for adults who have trouble falling asleep, staying asleep, or both. It's taken as a single tablet by mouth each night, usually starting at 5 mg and increasing to 10 mg if needed. Rather than boosting GABA activity like older sleep drugs, it works by blocking wake-promoting orexin signals in the brain.
Halcion
Halcion (triazolam) is a fast-acting benzodiazepine approved for short-term insomnia treatment, generally limited to 7 to 10 days. It's taken as a single tablet at bedtime, with doses ranging from 0.125 mg to 0.5 mg based on response and tolerability. It works by enhancing GABA activity in the brain to bring on sleep quickly.
Dayvigo vs. Halcion Side Effects
Dayvigo
Halcion
Dayvigo vs. Halcion Dosage
Dayvigo
Halcion
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 10 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 0.125 mg once daily | At the start |
| Maximum dose | 0.5 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Dayvigo
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 10 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Halcion
| STAGE | DOSE | WHEN |
| Starting dose | 0.125 mg once daily | At the start |
| Maximum dose | 0.5 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Dayvigo vs. Halcion Indications
Dayvigo
Dayvigo is FDA-approved for adults with insomnia marked by difficulty falling asleep, staying asleep, or both. It can be used nightly on an ongoing basis, with 12-month trial data showing sustained effectiveness and no rebound insomnia after stopping. It is not approved for children or for narcolepsy.
Difficulty falling asleep
Difficulty staying asleep
Approved for long-term nightly use
Not approved for pediatric patients
Not approved for narcolepsy
Halcion
Halcion is FDA-approved only for short-term insomnia treatment, typically no more than 7 to 10 days, in adults. It's intended to help with difficulty falling asleep rather than ongoing nightly use. Extended use requires careful re-evaluation because of dependence risk.
Short-term insomnia (7 to 10 days)
Difficulty falling asleep
Not approved for long-term use
Requires re-evaluation if extended
Not approved for pediatric patients
Dayvigo vs. Halcion Pros and Cons
Dayvigo
Dayvigo's orexin-blocking mechanism differs from benzodiazepines and Z-drugs, and long-term trial data support nightly use without rebound insomnia. As a newer brand-only medication, it comes with a higher price tag and no generic option yet.
Pros
Non-benzodiazepine mechanism, different dependence profile
FDA-approved for long-term nightly use
12-month data show no rebound insomnia after stopping
Cons
Newer brand-only drug, no generic available
Roughly $135 to $400 per month without insurance, before savings programs
Still a Schedule IV controlled substance with abuse potential
Risk of complex sleep behaviors like sleep-walking
Halcion
Halcion has decades of clinical use and a low generic price, making it accessible for short courses of insomnia treatment. Its boxed warnings for abuse, dependence, and dangerous interactions with opioids reflect the added risks that come with benzodiazepine therapy.
Pros
Long-established option in use since 1982
Roughly $20 to $65 per month without insurance, before savings programs
Fast onset for difficulty falling asleep
Cons
Boxed warning for abuse, misuse, and addiction
Boxed warning for dangerous interaction with opioids
Limited to 7 to 10 days of use before re-evaluation
Higher reported rate of memory lapses (amnesia)
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.